Latest News
Definium Therapeutics, Inc.
- Definium Therapeutics, Inc. Estimates – BOATS:DFTX
- RBC Capital reiterates Definium Therapeutics stock rating on strong trial data
- Definium Therapeutics: Outstanding Phase III Data De-Risks Pipeline, But Patience Required Ahead Of 2027
- Why is Definium Therapeutics stock gaining today?
- Definium therapeutics CFO Brandi Roberts sells $123,496 in shares By Investing.com
- Definium Therapeutics CCO Matthew Wiley sells $113,257 in common shares
- Definium Therapeutics CLO Mark Sullivan sells $513,845 in shares
- Definium Therapeutics CMO Daniel Karlin sells $396,894 in stock
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention?
- Form 4 Definium Therapeutics Inc For: 27 September By Investing.com
- Form 144 DEFINIUM THERAPEUTICS For: 26 September By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →